Cargando…
Nucleus‐specific RNAi nanoplatform for targeted regulation of nuclear lncRNA function and effective cancer therapy
In the context of cancer therapy, a recently identified therapeutic target is represented by the essential subtype of RNA transcripts ‐ the long noncoding RNAs (lncRNA). While this is the case, it is especially difficult to successfully regulate the expression of this subtype in vivo, particularly d...
Autores principales: | Huang, Zixian, Liu, Shaomin, Lu, Nan, Xu, Lei, Shen, Qian, Huang, Zhuoshan, Huang, Zhiquan, Saw, Phei Er, Xu, Xiaoding |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191018/ https://www.ncbi.nlm.nih.gov/pubmed/37325502 http://dx.doi.org/10.1002/EXP.20220013 |
Ejemplares similares
-
Vitamin D inhibits the proliferation of Oral Squamous Cell Carcinoma by suppressing lncRNA LUCAT1 through the MAPK pathway
por: Jin, Tingting, et al.
Publicado: (2020) -
Tumor-Associated Fibronectin Targeted Liposomal Nanoplatform for Cyclophilin A siRNA Delivery and Targeted Malignant Glioblastoma Therapy
por: Saw, Phei Er, et al.
Publicado: (2018) -
TME-Responsive Multistage Nanoplatform for siRNA Delivery and Effective Cancer Therapy
por: Cao, Shuwen, et al.
Publicado: (2021) -
Role of long non-coding RNAs in cancer: From subcellular localization to nanoparticle-mediated targeted regulation
por: Wei, Chunfang, et al.
Publicado: (2023) -
Nanocarrier-mediated antioxidant delivery for liver diseases
por: Li, Senlin, et al.
Publicado: (2020)